On November 27, Clariant, the world's leading maker of specialty chemicals, announced that its board of directors has approved the Executive Committee's proposal to update Clariant's strategic plan to further enhance value creation.
Under the proposal, the Clariant Board of Directors supports the Executive Committee in developing plans for further actions based on Clariant's existing strategy, including M & A activities, short-term portfolio management, potential shareholder returns, a comprehensive review of the cost basis and the search for more growth opportunities. Clariant recently announced that investing in sunliquid technology is an example of growth opportunities.
Clariant's growth strategy was unanimously supported by shareholders of Süd-Chemie, which own approximately 15% of the shares in issue, and shareholders of the vast majority of institutions. As a result, becoming a leader in Specialty Chemicals On the road, Clariant has gained wide support from global shareholders.
Prior to the AGM in March, Clariant will announce and explain details of these activities to investors in early 2018.
Under aggressive shareholder pressure, Clariant was forced to end its merger with Huntsman and Clarians' management fully realized that Clariant needed to pay for a strategic update in the wake of the merger More effort, so the new plan was developed.